GRITSTONE BIO, INC.

(GRTS)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
2.460 USD   +1.65%
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell Small Cap Comp Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2000 Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 3000E Value Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société GRITSTONE BIO, INC.
06/23GRITSTONE BIO : 2021 Annual Report
PU
06/21GRITSTONE BIO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/10GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
06/10Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA)..
AQ
06/08Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
06/02Gritstone Earns 2022 Great Place to Work Certification™
AQ
05/31Gritstone Announces Updated Overall Survival Results in Advanced Colorectal Cancer Pati..
AQ
05/17Gritstone to Participate in H.C. Wainwright Global Investment Conference
AQ
05/06CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Busin..
GL
05/06CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Busin..
GL
05/05GRITSTONE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
05/05Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update
AQ
05/02Gritstone to Release First Quarter 2022 Financial Results on May 5 and Announces Q&A Op..
GL
05/02Gritstone to Release First Quarter 2022 Financial Results on May 5 and Announces Q&A Op..
AQ
04/27Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
04/12Gritstone Presentations at AACR Further Support Expertise in Neoantigen Vaccine Design ..
AQ
03/30Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
03/10GRITSTONE BIO, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
03/10Gritstone Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides..
AQ
03/08Gritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology P..
AQ
02/24Gritstone to Participate in Cowen 42nd Annual Health Care Conference
GL
02/08Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
02/08Gritstone to Participate in Precision Oncology Panel at BIO CEO & Investor Conference
AQ
01/25Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
01/13Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualize..
AQ
01/10GRITSTONE BIO, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
01/06UNIVERSITY OF MANCHESTER : Early data for multivariant COVID-19 vaccine booster shows prom..
AQ
01/05GRITSTONE BIO : Announces Positive Clinical Results from First Cohort of a Phase 1 Study (..
PU
01/04GRITSTONE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/04Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (COR..
AQ
2021Gritstone Announces Presentations during Three Upcoming Investor Conferences
GL
2021GRITSTONE BIO : Announces Changes to Its Board of Directors - Form 8-K
PU
2021GRITSTONE BIO, INC. : Change in Directors or Principal Officers, Financial Statements and ..
AQ
2021Gritstone Announces Changes to Its Board of Directors
AQ
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
2021Gritstone bio Added to the Nasdaq Biotechnology Index
AQ
2021Gritstone bio and CEPI Expand Vaccine Agreement to Tackle Omicron Variant
AQ
2021The Omicron Variant of SARS-CoV-2 has Minimal Impact on the T Cell Epitopes (Targets) C..
AQ
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021Gritstone Announces Positive Preclinical Data in Non-Human Primate Challenge Study with..
AQ
2021GRITSTONE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
2021Gritstone Reports Third Quarter 2021 Financial Results and Business Update
AQ
2021GRITSTONE BIO : Announces Presentations during Five Upcoming Investor Conferences and Even..
AQ
2021GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
AQ
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021GRITSTONE BIO : Announces Dosing of First Volunteer in Trial Evaluating Self-Amplifying mR..
AQ
2021GRITSTONE BIO : SECURITIES PURCHASE AGREEMENT (Form 8-K)
PU
2021GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equ..
AQ
2021GRITSTONE BIO : Announces Dosing of First Solid Tumor Patient with Optimized SLATE “..
AQ
2021Gritstone Announces Positive Clinical Data with GRANITE (Individualized Neoantigen Immu..
GL
2021GRITSTONE BIO : Announces Private Placement Financing of $55.0 Million
AQ
2021Gritstone to Host Data Update on Neoantigen Oncology Programs for the Treatment of Soli..
GL
2021GRITSTONE BIO : Announces Presentations at Two Investor Conferences in September
AQ
2021GRITSTONE BIO : and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine ..
PU
2021GRITSTONE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021GRITSTONE BIO : and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine ..
AQ
2021GRITSTONE BIO : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
2021Gritstone to Host Key Opinion Leader Webinar on its Neoantigen Oncology Programs
GL
2021GRITSTONE BIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
AQ
2021GRITSTONE BIO : Reports Second Quarter 2021 Financial Results and Business Update
AQ
2021GRITSTONE BIO : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
2021GRITSTONE BIO, INC. : Change in Directors or Principal Officers, Financial Statements and ..
AQ
2021GRITSTONE BIO : Announces Management Changes, Including the Appointment of Celia Economide..
AQ
2021GRITSTONE BIO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021GRITSTONE BIO : Submission of Matters to a Vote Security Holders (Form 8-K)
PU
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021Gritstone to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
GL
2021GRITSTONE BIO, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021GRITSTONE BIO : Announces Changes to Its Board of Directors
AQ
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021GRITSTONE BIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
AQ
2021Gritstone Reports First Quarter 2021 Financial Results and Business Highlights
GL
2021GRITSTONE BIO, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin..
AQ
2021Gritstone Oncology Changes its Name to Gritstone bio to Reflect Expanded Therapeutic Fo..
GL
2021Gritstone Announces First Person Dosed with its Second-Generation COVID-19 Vaccine in P..
GL
1  2  3Next
Upcoming event on GRITSTONE BIO, INC.